{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:37:52Z","timestamp":1793255872107,"version":"4.5.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.thromres.2014.11.012","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T23:23:56Z","timestamp":1416525836000},"page":"231-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":278,"title":["Tranexamic acid \u2013 an old drug still going strong and making a revival"],"prefix":"10.1016","volume":"135","author":[{"given":"Lilian","family":"Tengborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Blomb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Berntorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2014.11.012_bb0005","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/272549a0","article-title":"Molecular mechanism of physiological fibrinolysis","volume":"272","author":"Wiman","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2014.11.012_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0049-3848(77)90003-2","article-title":"The specific interaction between plasminogen and fibrin. A physiological role of the lysine binding site in plasminogen","volume":"10","author":"Wiman","year":"1977","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.11.012_bb0015","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1172\/JCI109671","article-title":"Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor","volume":"65","author":"Sakata","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2014.11.012_bb0020","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1182\/blood-2011-02-333203","article-title":"The antifibrinolytic function of factor XIII is exclusively expressed through alpha(2)-antiplasmin cross-linking","volume":"117","author":"Fraser","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.11.012_bb0025","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.1097\/01.CCM.0000126361.00450.B1","article-title":"Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis","volume":"32","author":"Bajzar","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.thromres.2014.11.012_bb0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V68.1.275.275","article-title":"Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation","volume":"68","author":"Stricker","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.11.012_bb0035","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/00365518509155267","article-title":"The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma","volume":"45","author":"Kluft","year":"1985","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.thromres.2014.11.012_bb0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0033-1334483","article-title":"Plasminogen receptors: the first quarter century","volume":"39","author":"Miles","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2014.11.012_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2302\/kjm.11.105","article-title":"Amino-methyl-cyclohexane-carboxylic acid: AMCHA. A new potent inhibitor of fibrinolysis","volume":"11","author":"Okamoto","year":"1962","journal-title":"Keio J Med"},{"key":"10.1016\/j.thromres.2014.11.012_bb0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2302\/kjm.13.177","article-title":"An Active Stereo-Isomer (Trans-Form) of Amcha and Its Antifibrinolytic (Antiplasminic) Action in Vitro and in Vivo","volume":"13","author":"Okamoto","year":"1964","journal-title":"Keio J Med"},{"key":"10.1016\/j.thromres.2014.11.012_bb0055","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-0773.1965.tb01829.x","article-title":"Biochemistry and toxicology of amikapron; the antifibrinolytically active isomer of AMCHA. (A comparative study with epsilon-aminocaproic acid)","volume":"22","author":"Melander","year":"1965","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"10.1016\/j.thromres.2014.11.012_bb0060","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2014.11.012_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0049-3848(82)90214-6","article-title":"Fibrin gel structure and clotting time","volume":"25","author":"Blomback","year":"1982","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.11.012_bb0070","doi-asserted-by":"crossref","first-page":"24259","DOI":"10.1016\/S0021-9258(18)35759-4","article-title":"The effect of fibrin structure on fibrinolysis","volume":"267","author":"Gabriel","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2014.11.012_bb0075","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/j.1538-7836.2007.02755.x","article-title":"Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A","volume":"5","author":"Hvas","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.11.012_bb0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1182\/blood.V99.1.175","article-title":"Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A","volume":"99","author":"Lisman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.11.012_bb0085","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1749-6632.1968.tb20322.x","article-title":"Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA","volume":"146","author":"Andersson","year":"1968","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.thromres.2014.11.012_bb0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0609.1965.tb01300.x","article-title":"Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid","volume":"2","author":"Andersson","year":"1965","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0095","series-title":"The biological availability of Cyklokapron tablets compared with Cyklokapron solution administered orally","author":"Eriksson","year":"1971"},{"key":"10.1016\/j.thromres.2014.11.012_bb0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00554669","article-title":"Pharmacokinetics and bioavailability of tranexamic acid","volume":"20","author":"Pilbrant","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0105","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3109\/17453677608988725","article-title":"Diffusion of tranexamic acid to the joint","volume":"47","author":"Ahlberg","year":"1976","journal-title":"Acta Orthop Scand"},{"key":"10.1016\/j.thromres.2014.11.012_bb0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00016347009157244","article-title":"Human placental transfer of an antifibrinolytic agent (AMCA)","volume":"49","author":"Kullander","year":"1970","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.thromres.2014.11.012_bb0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/jcp.s3-14.1.41","article-title":"Clinical pharmacology of aminocaproic and tranexamic acids","volume":"14","author":"Nilsson","year":"1980","journal-title":"J Clin Pathol Suppl (R Coll Pathol)"},{"key":"10.1016\/j.thromres.2014.11.012_bb0120","first-page":"612","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial","volume":"59","author":"Williams-Johnson","year":"2010","journal-title":"West Indian Med J"},{"key":"10.1016\/j.thromres.2014.11.012_bb0125","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/cc10143","article-title":"High-dose tranexamic acid reduces blood loss in postpartum haemorrhage","volume":"15","author":"Ducloy-Bouthors","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.thromres.2014.11.012_bb0130","author":"Agency MPA"},{"key":"10.1016\/j.thromres.2014.11.012_bb0135","series-title":"Committee for proprietary medicinal products (CPMP) opinion following an article 10 referral: CYKLO-f (tranexamic acid)","author":"European Medicines Agency","year":"2014"},{"key":"10.1016\/j.thromres.2014.11.012_bb0140","series-title":"Drugs@FDA: Lysteda (tranexamic acid) label information","author":"US Food and Drug Administration","year":"2014"},{"key":"10.1016\/j.thromres.2014.11.012_bb0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/cc13965","article-title":"Tranexamic acid in pediatric trauma: why not?","volume":"18","author":"Beno","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.thromres.2014.11.012_bb0150","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/ndt\/14.3.750","article-title":"Acute renal cortical necrosis caused by an antifibrinolytic drug (tranexamic acid)","volume":"14","author":"Koo","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.thromres.2014.11.012_bb0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/ndt\/16.1.189","article-title":"Tranexamic-acid-induced acute renal cortical necrosis in a patient with haemophilia A","volume":"16","author":"Odabas","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.thromres.2014.11.012_bb0160","first-page":"160","article-title":"Medical therapy with tranexamic acid in autosomal dominant polycystic kidney disease patients with severe haematuria","volume":"32","author":"Peces","year":"2012","journal-title":"Nefrologia"},{"key":"10.1016\/j.thromres.2014.11.012_bb0165","doi-asserted-by":"crossref","first-page":"203579","DOI":"10.4061\/2011\/203579","article-title":"Tranexamic Acid treatment of life-threatening hematuria in polycystic kidney disease","volume":"2011","author":"Alameel","year":"2011","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0170","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1471-0528.1995.tb11293.x","article-title":"Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia","volume":"102","author":"Preston","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0175","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2516.2012.02748.x","article-title":"Combined treatment with APCC (FEIBA(R)) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A\u2013a two-centre experience","volume":"18","author":"Holmstrom","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.11.012_bb0180","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1055\/s-0038-1651301","article-title":"A double blind study of the effect of tranexamic acid in essential menorrhagia","volume":"20","author":"Vermylen","year":"1968","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1016\/j.thromres.2014.11.012_bb0185","series-title":"Haemorrhagic and Thrombotic Diseases","author":"Nilsson","year":"1974"},{"key":"10.1016\/j.thromres.2014.11.012_bb0190","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/s-0037-1616122","article-title":"No increased risk of venous thrombosis in women taking tranexamic acid","volume":"86","author":"Berntorp","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.11.012_bb0195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/157488612800492744","article-title":"The frequency of thrombotic events among adults given antifibrinolytic drugs for spontaneous bleeding: systematic review and meta-analysis of observational studies and randomized trials","volume":"7","author":"Ross","year":"2012","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.thromres.2014.11.012_bb0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1302\/0301-620X.93B1.24984","article-title":"Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement","volume":"93","author":"Sukeik","year":"2011","journal-title":"J Bone Joint Surg (Br)"},{"key":"10.1016\/j.thromres.2014.11.012_bb0205","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jss.2013.03.099","article-title":"A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty","volume":"184","author":"Tan","year":"2013","journal-title":"J Surg Res"},{"key":"10.1016\/j.thromres.2014.11.012_bb0210","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/bmj.2.5809.311","article-title":"Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease","volume":"2","author":"Forbes","year":"1972","journal-title":"Br Med J"},{"key":"10.1016\/j.thromres.2014.11.012_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0300-9785(75)80052-4","article-title":"Tooth extractions in hemophiliacs","volume":"4","author":"Ramstrom","year":"1975","journal-title":"Int J Oral Surg"},{"key":"10.1016\/j.thromres.2014.11.012_bb0220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0030-4220(85)90106-9","article-title":"Dental extractions in hemophilia: reflections on 10 years' experience","volume":"59","author":"Vinckier","year":"1985","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0225","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.tripleo.2004.06.071","article-title":"Management options for dental extraction in hemophiliacs: a study of 55 extractions (2000-2002)","volume":"99","author":"Frachon","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.thromres.2014.11.012_bb0230","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1601-0825.2005.01111.x","article-title":"Haemostatic management of intraoral bleeding in patients with von Willebrand disease","volume":"11","author":"Morimoto","year":"2005","journal-title":"Oral Dis"},{"key":"10.1016\/j.thromres.2014.11.012_bb0235","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2516.2004.00886.x","article-title":"Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization","volume":"10","author":"Pasi","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.11.012_bb0240","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0278-2391(86)90039-X","article-title":"Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery","volume":"44","author":"Sindet-Pedersen","year":"1986","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.thromres.2014.11.012_bb0245","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0901-5027(89)80026-8","article-title":"Oral surgery in patients with hereditary bleeding disorders. A survey of treatment in the Stockholm area (1974-1985)","volume":"18","author":"Ramstrom","year":"1989","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.thromres.2014.11.012_bb0250","first-page":"961","article-title":"Local antifibrinolytic treatment with tranexamic acid in hemophilic children undergoing dental extractions","volume":"41","author":"Waly","year":"1995","journal-title":"Egypt Dent J"},{"key":"10.1016\/j.thromres.2014.11.012_bb0255","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2516.2000.00423.x","article-title":"Proposal of a standard approach to dental extraction in haemophilia patients. A case-control study with good results","volume":"6","author":"Zanon","year":"2000","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.11.012_bb0260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2516.2000.00370.x","article-title":"Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases","volume":"6","author":"Federici","year":"2000","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.11.012_bb0265","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/archotol.128.12.1365","article-title":"Otolaryngologic surgery in children with von Willebrand disease","volume":"128","author":"Jimenez-Yuste","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.thromres.2014.11.012_bb0270","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-0038-1646899","article-title":"Changes of plasma coagulation and fibrinolysis in response to mental stress","volume":"62","author":"Jern","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.11.012_bb0275","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1365-2516.2010.02324.x","article-title":"A single centre experience in circumcision of haemophilia patients: Izmir protocol","volume":"16","author":"Yilmaz","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.11.012_bb0280","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/17453679609002323","article-title":"Total hip replacement in patients with hemophilia. 13 hips in 11 patients followed for 1-16 years","volume":"67","author":"Lofqvist","year":"1996","journal-title":"Acta Orthop Scand"},{"issue":"Suppl. 4","key":"10.1016\/j.thromres.2014.11.012_bb0685","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1745-6584.2005.0048.x","article-title":"Minimizing factor requirements for surgery without increased risk","volume":"10","author":"Schulman","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.11.012_bb0285","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/00365516409060511","article-title":"Determination of Menstrual Blood Loss","volume":"16","author":"Hallberg","year":"1964","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.thromres.2014.11.012_bb0290","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/00016346609158455","article-title":"Menstrual blood loss\u2013a population study. Variation at different ages and attempts to define normality","volume":"45","author":"Hallberg","year":"1966","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.thromres.2014.11.012_bb0295","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl. 7","key":"10.1016\/j.thromres.2014.11.012_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00016346609158476","article-title":"Clinical and experimental studies on menstrual blood loss","volume":"45","author":"Rybo","year":"1966","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.thromres.2014.11.012_bb0305","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1471-0528.1993.tb14272.x","article-title":"Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding","volume":"100","author":"Gleeson","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0310","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/00016346509155880","article-title":"Treatment of menorrhagia with epsilon aminocaproic acid. A double blind investigation","volume":"44","author":"Nilsson","year":"1965","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.thromres.2014.11.012_bb0315","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/bmj.4.5729.214","article-title":"Treatment of menorrhagia with tranexamic acid. A double-blind trial","volume":"4","author":"Callender","year":"1970","journal-title":"Br Med J"},{"key":"10.1016\/j.thromres.2014.11.012_bb0320","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/00016349409023453","article-title":"The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding","volume":"73","author":"Gleeson","year":"1994","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.thromres.2014.11.012_bb0325","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bmj.313.7057.579","article-title":"Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid","volume":"313","author":"Bonnar","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2014.11.012_bb0330","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0002-9378(11)90533-X","article-title":"A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia","volume":"164","author":"Milsom","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0335","first-page":"413","article-title":"Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety","volume":"4","author":"Leminen","year":"2012","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.thromres.2014.11.012_bb0340","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/AOG.0b013e3182839e0e","article-title":"Nonsurgical management of heavy menstrual bleeding: a systematic review","volume":"121","author":"Matteson","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0345","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/01443610600913932","article-title":"Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate","volume":"26","author":"Kriplani","year":"2006","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0350","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00001721-200204000-00008","article-title":"Desmopressin in the treatment of menorrhagia in women with no common coagulation factor deficiency but with prolonged bleeding time","volume":"13","author":"Edlund","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2014.11.012_bb0355","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2141.2009.07610.x","article-title":"Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid","volume":"145","author":"Kouides","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0360","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/AOG.0b013e3181f20177","article-title":"Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Lukes","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"319","key":"10.1016\/j.thromres.2014.11.012_bb0365","first-page":"e1","article-title":"A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding","volume":"205","author":"Freeman","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0370","first-page":"CD007872","article-title":"Tranexamic acid for preventing postpartum haemorrhage","author":"Novikova","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.thromres.2014.11.012_bb0375","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijgo.2011.09.001","article-title":"Tranexamic acid for postpartum bleeding","volume":"115","author":"Roberts","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.thromres.2014.11.012_bb0380","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3109\/14767058.2013.794210","article-title":"Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial","volume":"26","author":"Abdel-Aleem","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.thromres.2014.11.012_bb0385","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1745-6215-11-40","article-title":"The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial","volume":"11","author":"Shakur","year":"2010","journal-title":"Trials"},{"key":"10.1016\/j.thromres.2014.11.012_bb0390","first-page":"CD001421","article-title":"Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia","volume":"12","author":"Martin-Hirsch","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.thromres.2014.11.012_bb0395","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejogrb.2007.04.003","article-title":"Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study","volume":"137","author":"Caglar","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0400","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0030-4220(73)90303-4","article-title":"Tooth extractions in hemophiliacs after administration of a single dose of factor VIII or factor IX concentrate supplemented with AMCA","volume":"36","author":"Bjorlin","year":"1973","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0405","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/j.1552-4604.1987.tb05605.x","article-title":"Distribution of tranexamic acid to plasma and saliva after oral administration and mouth rinsing: a pharmacokinetic study","volume":"27","author":"Sindet-Pedersen","year":"1987","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0410","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0278-2391(10)80291-5","article-title":"Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants","volume":"51","author":"Ramstrom","year":"1993","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.thromres.2014.11.012_bb0415","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1160\/TH10-02-0139","article-title":"Management of dental extraction in patients undergoing anticoagulant treatment. Results from a large, multicentre, prospective, case-control study","volume":"104","author":"Bacci","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.11.012_bb0420","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00405-012-2184-3","article-title":"Systematic review and meta-analysis of the use of tranexamic acid in tonsillectomy","volume":"270","author":"Chan","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0425","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.ijporl.2012.04.028","article-title":"Tranexamic acid in adenotonsillectomy in children: a double-blind randomized clinical trial","volume":"76","author":"Brum","year":"2012","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0430","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.ijporl.2013.04.021","article-title":"Topical application of tranexamic acid after adenoidectomy: a double-blind, prospective, randomized, controlled study","volume":"77","author":"Albirmawy","year":"2013","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00016487409129566","article-title":"Epistaxis A clinical study with special reference to fibrinolysis","volume":"317","author":"Petruson","year":"1974","journal-title":"Acta Otolaryngol Suppl"},{"key":"10.1016\/j.thromres.2014.11.012_bb0440","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jth.12654","article-title":"Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease","volume":"12","author":"Gaillard","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.11.012_bb0445","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/gut.10.5.404","article-title":"Evidence for the release of gastric fibrinolytic activity into peripheral blood","volume":"10","author":"Cox","year":"1969","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2014.11.012_bb0450","first-page":"CD006640","article-title":"Tranexamic acid for upper gastrointestinal bleeding","volume":"1","author":"Gluud","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.thromres.2014.11.012_bb0455","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1160\/TH13-11-0952","article-title":"Gastrointestinal angiodysplasia and bleeding in von Willebrand disease","volume":"112","author":"Franchini","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.11.012_bb0460","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2165\/00044011-199510050-00005","article-title":"Application of pharmacokinetic data from healthy volunteers for the prediction of plasma concentration of tranexamic acid in surgical patients","volume":"10","author":"Benoni","year":"1995","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.thromres.2014.11.012_bb0465","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00402-013-1761-2","article-title":"Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials","volume":"133","author":"Zhou","year":"2013","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.thromres.2014.11.012_bb0470","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.otsr.2011.12.005","article-title":"Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control study in 70 patients","volume":"98","author":"Clave","year":"2012","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.thromres.2014.11.012_bb0475","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/000164700317411834","article-title":"Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty","volume":"71","author":"Benoni","year":"2000","journal-title":"Acta Orthop Scand"},{"key":"10.1016\/j.thromres.2014.11.012_bb0480","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.arth.2012.04.024","article-title":"Tranexamic acid for reduction of blood loss during total hip arthroplasty","volume":"27","author":"Imai","year":"2012","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.thromres.2014.11.012_bb0485","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1007\/s00586-013-2774-9","article-title":"Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials","volume":"22","author":"Li","year":"2013","journal-title":"Eur Spine J and the European Section of the Cervical Spine Research Society"},{"key":"10.1016\/j.thromres.2014.11.012_bb0490","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.knee.2013.05.014","article-title":"Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis","volume":"20","author":"Panteli","year":"2013","journal-title":"Knee"},{"key":"10.1016\/j.thromres.2014.11.012_bb0495","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s11999-013-3446-0","article-title":"Topical tranexamic Acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty","volume":"472","author":"Chang","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.thromres.2014.11.012_bb0500","article-title":"Tranexamic acid given into the wound reduces postoperative blood loss by half in major orthopaedic surgery","volume":"57\u201361","author":"Krohn","year":"2003","journal-title":"Eur J Surg Suppl"},{"key":"10.1016\/j.thromres.2014.11.012_bb0505","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00000542-199502000-00009","article-title":"The dose-response relationship of tranexamic acid","volume":"82","author":"Horrow","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1016\/j.thromres.2014.11.012_bb0510","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/00000539-200105000-00010","article-title":"Plasma tranexamic acid concentrations during cardiopulmonary bypass","volume":"92","author":"Fiechtner","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1016\/j.thromres.2014.11.012_bb0515","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00000542-200208000-00016","article-title":"Pharmacokinetics of tranexamic acid during cardiopulmonary bypass","volume":"97","author":"Dowd","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.thromres.2014.11.012_bb0520","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1365-2044.2012.07266.x","article-title":"Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass","volume":"67","author":"Sharma","year":"2012","journal-title":"Anaesthesia"},{"key":"10.1016\/j.thromres.2014.11.012_bb0525","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/ACO.0b013e32833ff3eb","article-title":"Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era","volume":"24","author":"Koster","year":"2011","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0530","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1213\/ANE.0b013e3181c92b23","article-title":"High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients","volume":"110","author":"Murkin","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.thromres.2014.11.012_bb0535","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s701-002-8275-z","article-title":"Epileptic seizures following cortical application of fibrin sealants containing tranexamic acid in rats","volume":"144","author":"Schlag","year":"2002","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.thromres.2014.11.012_bb0540","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1172\/JCI63375","article-title":"Tranexamic acid concentrations associated with human seizures inhibit glycine receptors","volume":"122","author":"Lecker","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2014.11.012_bb0545","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/IMI.0b013e3182747699","article-title":"Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011","volume":"7","author":"Menkis","year":"2012","journal-title":"Innovations (Phila)"},{"key":"10.1016\/j.thromres.2014.11.012_bb0550","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/bja\/aet255","article-title":"Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass","volume":"111","author":"Grassin-Delyle","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.thromres.2014.11.012_bb0555","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/ALN.0b013e3182a443e8","article-title":"Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass","volume":"120","author":"Sigaut","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.thromres.2014.11.012_bb0560","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/CH-131782","article-title":"Prospective clinical trial on dosage optimizing of tranexamic acid in non-emergency cardiac surgery procedures","volume":"55","author":"Waldow","year":"2013","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.thromres.2014.11.012_bb0565","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/ALN.0b013e318283c83a","article-title":"A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery","volume":"118","author":"Grassin-Delyle","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.thromres.2014.11.012_bb0570","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2141.2009.08021.x","article-title":"Haemostasis and thrombosis in liver disease","volume":"148","author":"Roberts","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0575","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1538-7836.2012.04770.x","article-title":"Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure","volume":"10","author":"Lisman","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.11.012_bb0580","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tacc.2012.12.004","article-title":"Point-of-care coagulation monitoring during liver transplantation","volume":"3","author":"Agarwal","year":"2013","journal-title":"Trends Anaesth Crit Care"},{"key":"10.1016\/j.thromres.2014.11.012_bb0585","first-page":"CD008085","article-title":"Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver resection","volume":"4","author":"Gurusamy","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.thromres.2014.11.012_bb0590","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.urology.2004.07.008","article-title":"Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy","volume":"64","author":"Rannikko","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.thromres.2014.11.012_bb0595","doi-asserted-by":"crossref","first-page":"d5701","DOI":"10.1136\/bmj.d5701","article-title":"Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial","volume":"343","author":"Crescenti","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2014.11.012_bb0600","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/jth.12078","article-title":"The incidence and magnitude of fibrinolytic activation in trauma patients","volume":"11","author":"Raza","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.11.012_bb0605","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1213\/ANE.0b013e31823b6683","article-title":"Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood","volume":"114","author":"Dirkmann","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.thromres.2014.11.012_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17100","article-title":"The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.thromres.2014.11.012_bb0615","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5694\/mja13.10747","article-title":"PATCH-Trauma study. Trauma and tranexamic acid","volume":"199","author":"Gruen","year":"2013","journal-title":"Med J Aust"},{"issue":"iii-xii","key":"10.1016\/j.thromres.2014.11.012_bb0620","first-page":"1","article-title":"CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial","volume":"16","author":"Perel","year":"2012","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.thromres.2014.11.012_bb0625","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1745-6215-13-87","article-title":"CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial","volume":"13","author":"Dewan","year":"2012","journal-title":"Trials"},{"key":"10.1016\/j.thromres.2014.11.012_bb0630","first-page":"CD001245","article-title":"Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage","author":"Roos","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.thromres.2014.11.012_bb0635","first-page":"CD001245","article-title":"Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage","volume":"8","author":"Baharoglu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.thromres.2014.11.012_bb0640","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3171\/jns.2002.97.4.0771","article-title":"Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study","volume":"97","author":"Hillman","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.thromres.2014.11.012_bb0645","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1745-6215-14-143","article-title":"Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial","volume":"14","author":"Germans","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.thromres.2014.11.012_bb0650","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1213\/01.ANE.0000054001.37346.03","article-title":"Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery","volume":"96","author":"Pleym","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1016\/j.thromres.2014.11.012_bb0655","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/EJA.0b013e32834050ab","article-title":"Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy","volume":"28","author":"Weber","year":"2011","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0660","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/bjh.12189","article-title":"A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor","volume":"160","author":"He","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.11.012_bb0665","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(12)60286-4","article-title":"Bringing women to the forefront of science and medicine","volume":"379","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2014.11.012_bb5000","series-title":"Tests used in the clinical evaluation of the fibrinolytic system","author":"Wiman","year":"2008"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814006215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814006215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T06:09:36Z","timestamp":1717567776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814006215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":135,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0049384814006215"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.11.012","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tranexamic acid \u2013 an old drug still going strong and making a revival","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}